Cargando…
Enhancing electron transfer of a semiconducting polymer for type I photodynamic and photothermal synergistic therapy
Tumor hypoxia is responsible for the reduced therapeutic efficacy of type II photodynamic therapy (PDT) because of the dependence of cellular oxygen during (1)O(2) generation. Type I PDT may be a better strategy to overcome the disadvantages of hypoxia for enhanced theranostics. Herein, a new semico...
Autores principales: | Cui, Cao, Su, Xuehua, Guo, Yongchun, Zhu, Jun, Chen, Zimeng, Qin, Wei, Guo, Yihang, Tao, Wenming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527290/ https://www.ncbi.nlm.nih.gov/pubmed/36199364 http://dx.doi.org/10.3389/fbioe.2022.1004921 |
Ejemplares similares
-
Albumin-Stabilized Manganese Oxide/Semiconducting Polymer Nanocomposites for Photothermal-Chemodynamic Therapy of Hepatic Carcinoma
por: Su, Qi, et al.
Publicado: (2022) -
Thiadiazoloquinoxaline-Based Semiconducting Polymer Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Therapy
por: Gu, Xuxuan, et al.
Publicado: (2021) -
pH-Sensitive and Charge-Reversal Polymeric Nanoplatform Enhanced Photothermal/Photodynamic Synergistic Therapy for Breast Cancer
por: Wang, Wenyan, et al.
Publicado: (2022) -
Nanomaterials for the treatment of bacterial infection by photothermal/photodynamic synergism
por: Yan, Zhaochen, et al.
Publicado: (2023) -
Biomimetic Cucurbitacin B-Polydopamine Nanoparticles for Synergistic Chemo-Photothermal Therapy of Breast Cancer
por: Leng, Junke, et al.
Publicado: (2022)